Insight Wealth Strategies LLC Has $3.13 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Insight Wealth Strategies LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 6,195 shares of the healthcare conglomerate’s stock after selling 197 shares during the period. Insight Wealth Strategies LLC’s holdings in UnitedHealth Group were worth $3,134,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. State Street Corp boosted its position in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after purchasing an additional 563,554 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after buying an additional 318,039 shares during the last quarter. Franklin Resources Inc. increased its holdings in UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares during the last quarter. International Assets Investment Management LLC lifted its stake in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH traded up $0.26 during trading on Monday, hitting $513.26. 2,388,004 shares of the stock traded hands, compared to its average volume of 3,186,897. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a 50 day moving average price of $559.83 and a 200 day moving average price of $561.31. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market cap of $472.34 billion, a price-to-earnings ratio of 33.44, a PEG ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.56 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s payout ratio is presently 54.72%.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $627.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.